Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Date:5/6/2008

iodine in reducing local catheter site infections. The company achieved its goal of enrolling 1,850 patients at 58 clinical trial sites in the United States and Europe. CLIRS is being conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration (FDA).

First Quarter 2008 Financial Results

For the first quarter ended March 31, 2008, Cadence reported a net loss of $13.7 million, or $0.42 per share, compared to a net loss of $9.6 million, or $0.34 per share, for the same period in 2007.

As of March 31, 2008, Cadence held cash and cash equivalents of $91.4 million, which included proceeds from the registered direct offering completed in February 2008, pursuant to which Cadence issued and sold approximately 9.2 million shares of common stock at a price of $5.34 per share, and received net proceeds of approximately $49.1 million.

Operating expenses for the first quarter ended March 31, 2008, were $13.8 million, an increase of $3.4 million from the $10.4 million reported for the same period in 2007. This increase was primarily a result of $1.7 million of additional research and development costs related to ongoing Phase III clinical trials and pre-commercialization manufacturing development activities for Acetavance and Omigard. Other supporting costs for research and development activities increased $0.5 million, which included a $0.2 million increase in stock-based compensation.

In addition, the increased operating expenses were due to a $0.3 million increase in market research and personnel-related activities for Omigard, and an increase of $0.8 million in general and administrative expenses, including a $0.4 million increase in stock-based compensation charges.

Acetavance(TM) Clinical Program Update

o Following the announcement of results for Acetavance Studies 301 and

302 in January 2008, Cadence initiated discussions with the FDA to

determine if the company may need to
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
3. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
4. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
5. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
6. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
7. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
8. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
9. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
10. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
11. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Hovione today announced that its API plant in ... pre-approval inspection by the US Food and Drug Administration (FDA). ... Safety Officer, Ms. Britanny Terhar , lasted 5 days ... concluded on the 25 th . The inspection confirmed the ... Good Manufacturing Practices (GMP) and no Form 483 observations were ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... in New York results of AFF008, ... Parkinson,s disease. PD01A is the first therapy against the protein ... The Michael J. Fox Foundation for Parkinson,s Research ... and presented at the press conference on the impact a ...
(Date:7/31/2014)... 2014 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics ... a conference call on Thursday, August 14, 2014, at 4:30 ... ended June 30, 2014. Financial results will be issued in ... Chairman, President and CEO James LaFrance will host ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. Eastern ...
Breaking Medicine Technology:Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... Life Technologies Corporation (NASDAQ: LIFE ) ... with GlaxoSmithKline Biologicals S.A. (GSK) to develop a diagnostic ... GSK candidate cancer immunotherapy. Specifically, Life will develop a ... candidate designed to identify patients likely to benefit from ...
... (Cayman) Inc. (NYSE: WX ), a leading ... operations in China and the United States, today announced ... quarter of 2011 after the New York Stock Exchange ... Friday morning, November 11, 2011 Shanghai time). The earnings ...
Cached Medicine Technology:Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 2Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 3Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 4WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release 2
(Date:7/31/2014)... MI (PRWEB) July 31, 2014 The vineyards ... of the upcoming harvest. And, to celebrate, folks are gearing ... and Sunday, September 6 and 7, 2014 along the ... is an optional walk or run through the vineyards start-ing ... in Suttons Bay. A unique course between rows of grapevines ...
(Date:7/31/2014)... July 31, 2014 Cosmetic Town has ... patients and doctors. Doctors will be able to verify ... reviews , which guarantees their authenticity. This ... the site to receive information that has been verified ... validation system allows Cosmetic Town to filter out fake ...
(Date:7/31/2014)... 31, 2014 NEWwoodworks, fine woodworking group ... their brand presence with a website dedicated to highlighting ... NEWwoodworks has specialized in handcrafted cabinetry, furniture, stairs ... has earned a reputation for taking on the remarkable, ... They commonly craft with reclaimed wood, often using near ...
(Date:7/31/2014)... US Hair Restoration Founder, Dr. Parsa Mohebi, has recently ... Mohebi Hair Restoration. Since first opening in 2008, US ... and around the world, who traveled to one of its ... patients achieved the full benefits of a variety of hair ... Dr. Mohebi. They have come to understand how his ...
(Date:7/31/2014)... July 31, 2014 Daily Gossip indicates ... pain killers for this health problem. However, this is ... new program was created by Peter Bansby, who decided ... sufferers from all over the world find a unique ... people wish to view pros and cons from a ...
Breaking Medicine News(10 mins):Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:US Hair Restoration Becomes Parsa Mohebi Hair Restoration 2Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2
... NEW YORK, July 1 Prostate cancer is the ... caught early, prostate cancer,has a 90% cure rate., ... and,Minimally Invasive Surgery, Department of Urology, at Mount Sinai ... to wait until there are,warning signs, because by then ...
... Meet Aggressive Hospital Opening Schedule; Eases Ongoing IT Development ... ... RIOJA, Spain, July 1 TIBCO Software Inc.,(Nasdaq: TIBX ) ... Rioja has deployed its real-time integration,infrastructure. The project at Servicio Riojano ...
... Growth In All Existing Markets -, LONG ... Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider ... surpassed,67,000 beds served, a five percent increase over ... all five of its institutional facilities,including Long Beach, ...
... July 1 ETHICON, Inc., a Johnson &,Johnson ... offer from One Equity Partners to acquire the ... process to,prepare for the divestiture of the Professional ... process and receipt of the offer has decided ...
... Healthcare Underwriters Group Mutual of Ohio (HUOH), the only medical liability ... by Ohio physicians, announced today that it will make its first ... Board of Directors after the company achieved outstanding loss results for ... single paid loss. , ...
... support organization for families going through the natural ... is hosting its 31st national conference July 18-20 ... and grandparents, as well as professionals who provide ... include well-known speakers, more than 100 workshops covering ...
Cached Medicine News:Health News:With Prostate Cancer: Waiting for Symptoms Is Not an Option 2Health News:Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations 2Health News:Chem Rx Corporation Surpasses 67,000 Beds Served 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 3Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 4Health News: Great Doctors Produce Great Results (Healthcare Underwriters Group Mutual of Ohio Pays A Cash Dividend): -- Healthcare Underwriters Group Mutual of Ohio Pays Its First Cash Distribution to Its Insured Owners 2Health News:Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: